Ascelia Pharma AB (publ) Working Capital to Net Assets Ratio
Ascelia Pharma AB (publ) working capital to net assets ratio. Ascelia Pharma AB (publ) (ACE) has a Working Capital to Net Assets ratio of 49.3% as of September 2025. Working capital of Skr56.45 Million (current assets of Skr78.18 Million minus current liabilities of Skr21.73 Million) is measured against net assets of Skr114.40 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Ascelia Pharma AB (publ) to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Ascelia Pharma AB (publ) (2016–2024)
Working capital to net assets ratio of Ascelia Pharma AB (publ) from 2016 to 2024. This chart shows how Ascelia Pharma AB (publ)'s Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 49.3%, reflecting working capital of Skr56.45 Million against net assets of Skr114.40 Million SEK. See ACE defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Ascelia Pharma AB (publ) Working Capital to Net Assets Ratio by Year (2016–2024)
Ascelia Pharma AB (publ) working capital to net assets ratio by year from 2016 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Ascelia Pharma AB (publ) from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Ascelia Pharma AB (publ) (ACE) total assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 27.5% | Skr21.74 Million | Skr78.94 Million | Skr83.72 Million | Skr61.98 Million | ▲ +5.5 pp |
| 2023 | 22.0% | Skr16.37 Million | Skr74.33 Million | Skr28.94 Million | Skr12.57 Million | ▼ -46.2 pp |
| 2022 | 68.2% | Skr123.35 Million | Skr180.86 Million | Skr160.87 Million | Skr37.52 Million | ▼ -12.8 pp |
| 2021 | 81.1% | Skr249.50 Million | Skr307.83 Million | Skr274.61 Million | Skr25.11 Million | ▲ +5.7 pp |
| 2020 | 75.4% | Skr177.96 Million | Skr236.06 Million | Skr196.32 Million | Skr18.36 Million | ▼ -0.5 pp |
| 2019 | 75.9% | Skr179.88 Million | Skr237.06 Million | Skr192.95 Million | Skr13.07 Million | ▼ -3.4 pp |
| 2018 | 79.3% | Skr218.88 Million | Skr276.07 Million | Skr230.08 Million | Skr11.20 Million | ▲ +30.4 pp |
| 2017 | 48.9% | Skr54.66 Million | Skr111.73 Million | Skr59.08 Million | Skr4.42 Million | ▲ +22.5 pp |
| 2016 | 26.4% | Skr20.50 Million | Skr77.60 Million | Skr23.29 Million | Skr2.79 Million | — |